Clin2
NCT07712926Worth exploringNot yet recruiting

Dengue vaccine for children and teens

Dengue Fever With Warning Signs

Part of Infections clinical trials.

This trial tests a two-dose dengue vaccine compared to the standard one-dose vaccine in children and teens who have never had dengue. It checks if the two-dose version works better and if a new manufacturing version works the same.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,765 people
Ages
2 years to 17 years
Study type
Interventional

Who can take part

  • Age 2 to 17 years old
  • Never had dengue (confirmed by a blood test)
  • No previous dengue vaccine
  • Live in or visit a study site in certain areas
  • No serious health problems (like heart, lung, or immune system issues)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06843226Recruiting
Dengue vaccine study for children and teens

This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.

Banjarmasin, South Kalimantan
NCT06665035Recruiting· Phase 3
Dengue vaccine study for infants and toddlers

This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.

Barranquilla, Atlántico
NCT06891950Recruiting· Phase 3
Dengue vaccine study for healthy older adults

This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.

Curitiba, Paraná
NCT06776692Recruiting
Dengue vaccine immunity study for all ages

This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.

Negrar, VR
NCT04839757Recruiting
Testing a dengue vaccine plan for kids in the Caribbean

This trial looks at a dengue vaccine strategy in children ages 9 to 17 in Martinique and Guadeloupe. It may help protect kids from dengue, based on how the vaccine is accepted and how the study is carried out.

Fort-de-France
NCT07831473Not yet recruiting· Phase 1
Safety and effects of an investigational dengue vaccine

This early-stage trial tests a new dengue vaccine in healthy adults. Participants will receive the vaccine and later be exposed to a weakened dengue virus to see if the vaccine protects them, while being closely monitored for safety and immune response.

Baltimore, Maryland

Hear when a new Dengue Fever With Warning Signs trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.